Ghrelin
Also known as: GHRL, growth hormone-releasing peptide endogenous, ghrelinergic peptide, acyl ghrelin
Ghrelin is a research compound. Not approved for human therapeutic use outside specific investigational contexts.
Overview
Endogenous 28-amino acid peptide secreted primarily by the stomach that functions as both the primary hunger signal and a potent growth hormone secretagogue. The n-octanoyl modification at Ser-3 (acylated form) is required for GHS-R1a receptor binding and GH-stimulating activity. Understanding ghrelin explains the mechanism behind the entire GHRP class of research peptides.
Research Summary
Ghrelin was discovered in 1999 as the endogenous ligand for the GHS-R1a receptor. Its acylated form activates GH release from the pituitary, stimulates appetite via NPY/AgRP hypothalamic neurons, and modulates energy homeostasis and fat storage. The des-acyl form (majority of circulating ghrelin) lacks GHS-R1a activity but has independent cardiovascular and cellular effects.
Dosing Range
low
0.5mcg/kg
moderate
1mcg/kg
high
2mcg/kg
Units: mcg/kg · Frequency: IV or SC bolus; endogenous levels peak pre-meal
Dosing ranges are aggregated from preclinical research and community protocols. Not medical dosing guidance.
Administration Routes
Reconstitution Notes
Reconstitute acylated ghrelin carefully — the n-octanoyl modification at Ser-3 is chemically labile. Use sterile water; keep at -20°C for long-term storage. Avoid repeated freeze-thaw cycles. Use within 24h once thawed.Step-by-step reconstitution guide →
Supplies you'll need
Affiliate links — Research Stack may earn a small commission at no extra cost to you.
Reported Side Effects
- Appetite stimulation
- Transient hyperglycemia
- Water retention
- GH pulse stimulation
- Increased fat storage (chronic elevation)
Research Papers
2 peer-reviewed sourcesCommunity Experiences
Aggregated from public forums. Anecdotal — not clinical evidence.
Community discussion of ghrelin's role in understanding GHRP mechanisms and appetite effects.
View original threadScientific discussions on ghrelin's role in metabolism and hunger signaling.
View original threadOverview
Ghrelin is one of the most important peptide hormones discovered in the past three decades. Its identification in 1999 by Kojima and colleagues at Curran & Genentech/Osaka University fundamentally reframed understanding of appetite and growth hormone regulation.
Before ghrelin's discovery, researchers knew the GHS-R1a receptor existed (it was the target of synthetic GHRP research compounds) but didn't know the endogenous ligand. Ghrelin was that missing ligand — produced primarily by X/A-like cells in the gastric fundus and secreted in pulses that rise pre-meal and fall post-meal.
Mechanism
The Acylation Requirement
The unique feature of ghrelin is its post-translational modification: an n-octanoyl (C8:0) group attached to the hydroxyl group of serine at position 3. This acylation is catalyzed by ghrelin O-acyltransferase (GOAT) and is absolutely required for GHS-R1a binding.
- Acyl ghrelin (active): ~20% of circulating ghrelin; binds GHS-R1a → GH release + appetite
- Des-acyl ghrelin (inactive at GHS-R1a): ~80% of circulating ghrelin; has independent effects via unknown receptors
GH Secretion Pathway
- Acyl ghrelin binds GHS-R1a in the hypothalamus and anterior pituitary
- In the hypothalamus: stimulates GHRH release and inhibits somatostatin (removing GH's primary brake)
- Direct pituitary action: activates somatotrophs to release GH in pulses
- GH → liver → IGF-1 production
Appetite Regulation
Ghrelin activates NPY (neuropeptide Y) and AgRP (agouti-related peptide) neurons in the arcuate nucleus of the hypothalamus — the primary orexigenic (appetite-stimulating) circuit. This is why all GHS-R1a agonists (GHRP-6, MK-677, ipamorelin) stimulate appetite to varying degrees.
Ghrelin and the GHRP Class
Understanding ghrelin clarifies why different GHRPs have different appetite profiles:
| Compound | GHS-R1a affinity | Appetite effect | |----------|-----------------|-----------------| | Ghrelin | Native ligand | Strong | | GHRP-6 | High | Strong | | MK-677 | High | Strong | | GHRP-2 | High | Moderate | | Ipamorelin | Selective | Mild |
Ipamorelin's lower appetite drive reflects its more selective receptor engagement profile — it doesn't fully activate all the downstream pathways that full GHS-R1a agonists like ghrelin trigger.
Research Context
Ghrelin itself is rarely used as a research peptide in the way synthetic GHRPs are — its instability (the acyl group hydrolyzes readily), very short half-life, and the availability of stable synthetic analogues make it more valuable as a reference standard than a research tool. Its main importance is mechanistic: understanding ghrelin is foundational to understanding the entire GH secretagogue field.
Related Performance Peptides
ACE-031
PerformanceACVR2B-Fc · ActRIIB-Fc fusion protein
Soluble form of activin type IIB receptor (ActRIIB-Fc fusion protein) that acts as a myostatin and activin trap. Blocks…
CJC-1295
PerformanceCJC-1295 DAC · CJC-1295 without DAC (Mod GRF 1-29)
CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analog. It stimulates the pituitary gland to release gro…
CJC-1295 / Ipamorelin Stack
PerformanceCJC-1295 Ipamorelin · Mod GRF 1-29 Ipamorelin
The CJC-1295 (without DAC) and Ipamorelin combination is the most widely researched and community-validated growth hormo…